Page last updated: 2024-08-17

dichloroacetic acid and Metabolic Diseases

dichloroacetic acid has been researched along with Metabolic Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, JH; Bae, EJ; Bae, MA; Chi, YI; Choi, WI; Dighe, M; Gim, HE; Jaladi, AK; Jang, YK; Jeon, JH; Jeon, YH; Jung, KY; Kim, M; Lee, D; Lee, GH; Lee, IK; Lee, KM; Lee, S; Lee, T; Liu, KH; Pagire, HS; Pagire, SH; Park, S; Song, JS; Yoo, EK	1
Jahn, SC; James, MO; Rowland-Faux, L; Stacpoole, PW	1
James, MO; Stacpoole, PW	1

Reviews

1 review(s) available for dichloroacetic acid and Metabolic Diseases

Article	Year
Pharmacogenetic considerations with dichloroacetate dosing. Pharmacogenomics, 2016, Volume: 17, Issue:7 Topics: Amino Acid Sequence; Animals; Biotransformation; Chlorides; Dichloroacetic Acid; Glutathione Transferase; Humans; In Vitro Techniques; Liver; Metabolic Diseases; Neoplasms; Pharmacogenomic Testing; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase	2016

Article

Year

Pharmacogenetic considerations with dichloroacetate dosing.

Pharmacogenomics, 2016, Volume: 17, Issue:7

Topics: Amino Acid Sequence; Animals; Biotransformation; Chlorides; Dichloroacetic Acid; Glutathione Transferase; Humans; In Vitro Techniques; Liver; Metabolic Diseases; Neoplasms; Pharmacogenomic Testing; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase

2016

Other Studies

2 other study(ies) available for dichloroacetic acid and Metabolic Diseases

Article	Year
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases. Journal of medicinal chemistry, 2019, 01-24, Volume: 62, Issue:2 Topics: Administration, Oral; Animals; Anthraquinones; Binding Sites; Cell Line; Half-Life; Humans; Hypoglycemic Agents; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Microsomes, Liver; Molecular Docking Simulation; Obesity; Protein Kinase Inhibitors; Protein Kinases; Rats; Structure-Activity Relationship	2019
Chloride concentrations in human hepatic cytosol and mitochondria are a function of age. Biochemical and biophysical research communications, 2015, Apr-10, Volume: 459, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Child, Preschool; Chlorides; Chromatography, High Pressure Liquid; Cytosol; Dichloroacetic Acid; Enzyme Inhibitors; Female; Glutathione Transferase; Humans; Infant; Infant, Newborn; Ion Transport; Liver; Male; Metabolic Diseases; Middle Aged; Mitochondria, Liver; Young Adult	2015

Article

Year

Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.

Journal of medicinal chemistry, 2019, 01-24, Volume: 62, Issue:2

Topics: Administration, Oral; Animals; Anthraquinones; Binding Sites; Cell Line; Half-Life; Humans; Hypoglycemic Agents; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Obese; Microsomes, Liver; Molecular Docking Simulation; Obesity; Protein Kinase Inhibitors; Protein Kinases; Rats; Structure-Activity Relationship

2019

Chloride concentrations in human hepatic cytosol and mitochondria are a function of age.

Biochemical and biophysical research communications, 2015, Apr-10, Volume: 459, Issue:3

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Child; Child, Preschool; Chlorides; Chromatography, High Pressure Liquid; Cytosol; Dichloroacetic Acid; Enzyme Inhibitors; Female; Glutathione Transferase; Humans; Infant; Infant, Newborn; Ion Transport; Liver; Male; Metabolic Diseases; Middle Aged; Mitochondria, Liver; Young Adult

2015